←Back to Expert Scholars
Translational Medicine / 转化医学Pan RAS Inhibitors
Kevan Shokat
PhD
🏢University of California San Francisco🌐USA
Professor of Cellular and Molecular Pharmacology
115
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kevan Shokat made the seminal discovery that enabled covalent inhibition of KRAS G12C, launching the modern era of RAS drug discovery. His laboratory continues to advance pan RAS and broader RAS targeting strategies. He is a pioneer of chemical biology approaches to undruggable targets.
Share:
🧪Research Fields 研究领域
KRAS
covalent inhibitors
chemical biology
drug discovery
RAS
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kevan Shokat 的研究动态
Follow Kevan Shokat's research updates
留下邮箱，当我们发布与 Kevan Shokat（University of California San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment